GGrantIndex
Sort

40,608 grants matching prostate cancer

A Systems Biology Platform for Integrative Cancer Biology Research

$625,485
Yuri V. Nikolsky · Genego, Inc. · R44 · FY2010 · CA

Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression

$625,460
Edward Giovannucci · Harvard School Of Public Health · R01 · FY2012 · CA

Personalized Immunotherapy of Patients with Ovarian Cancer

$625,397
Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA

A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy

$625,359
Cohava Gelber · Serpin Pharma, Llc · R44 · FY2025 · CA

A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS

$625,358
Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2014 · ES

CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS

$625,318
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii · · FY2018 · Defense Health Agency

PALS: Prostate Cancer Active Lifestyle Study

$625,292
Jonathan L. Wright · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

Adaptive Percutaneous Prostate Interventions using Sensorized Needle

$625,285
Junichi Tokuda · Brigham And Women'S Hospital · R01 · FY2024 · CA

Culturally Adapted Cognitive Behavioral Stress and Self-Management (CCBSM)

$625,257
Frank J Penedo · University Of Miami Coral Gables · R01 · FY2020 · CA

The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking

$625,207
Kim Butts Pauly · Stanford University · R01 · FY2020 · CA

Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care

$625,180
Tina Hernandez-Boussard · Stanford University · R01 · FY2015 · CA

Image-guided TRAIL-enhanced CAR T-cell immunotherapy

$625,160
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

IGF::OT::IGF PROSTATE CANCER PREVENTION BY ASPIRIN AND/OR OTHER NSAIDS TORFP 2016-E03HHSN2612015000381PERIOD OF PERFORMANCE: 07/07/2016 - 03/06/2019

$625,093
Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2016 · CA

Computerized histologic image predictor of cancer outcome

$624,988
Anant Madabhushi · Case Western Reserve University · R01 · FY2017 · CA

Phase III Trial of Selenium for Prostate Cancer Prevention

$624,974
Frederick R Ahmann · University Of Arizona · R01 · FY2006 · CA

Core D: Data Management, Biostatistics, and Bioinformatics

$624,954
David V Conti · University Of Southern California · U19 · FY2022 · CA

MOLECULAR RECLASSIFICATION OF PROSTATIC CANCER

$624,909
University Of Pittsburgh At Pittsburgh · U01 · FY2001 · CA

Development

$624,895
Ana M Navarro · University Of California, San Diego · U54 · FY2008 · CA

Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients

$624,859
Scarlett L Gomez · University Of California, San Francisco · R01 · FY2018 · CA

Stanford Molecular and Cellular Characterization Laboratory

$624,820
James D Brooks · Stanford University · U01 · FY2016 · CA

Chicago Cancer Navigation Project

$624,741
Charles Lee Bennett · Northwestern University At Chicago · U01 · FY2006 · CA

Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation Center

$624,712
Martin G Sanda · Emory University · U01 · FY2014 · CA

Exercise as Interception Therapy in Primary High Risk Cancer

$624,661
Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Multilevel Resilience Trajectories in the Transition to Cancer Survivorship

$624,505
Crystal L Park · University Of Connecticut Storrs · UH3 · FY2020 · CA

Molecular Genomics Core

$624,450
David W Craig · University Of Southern California · P30 · FY2023 · CA